PUMA BIOTECHNOLOGY, INC.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2026 | $64.3M | $192.7M | $36.2M |
| Jun 2026 | $54.2M | $192.7M | $36.5M |
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2026 | $64.3M | $192.7M | $36.2M |
| Jun 2026 | $54.2M | $192.7M | $36.5M |